AMPH 8-K 2026-11-05

Amphastar Pharmaceuticals, Inc. (AMPH) 8-K dated 2026-11-05 — accession 0001297184-26-000051.

Amphastar Pharmaceuticals, Inc. (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.

Amphastar Pharmaceuticals, Inc. filed a 8-K on 2026-11-05. Accession 0001297184-26-000051.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported AMPH revenue for 2025-12-31 was $719.9M. Net income was $98.1M. Revenue was down 1.7% from 2024-12-31 to 2025-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 16.4.

Not investment advice. The AMPH SEC hub lists recent forms. The stock page is the research view.